Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.

about

Comparison of delivery strategies for pharmacogenetic testing services

P2860

Q26860925-87326FEC-22C8-4CE5-A093-DE1A5C9CD964

P2860

Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.

Item

http://www.wikidata.org/entity/Q38094070

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.

@en

type

Item

label

Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.

@en

prefLabel

Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.

@en

P1476

Pharmacogenetics in cardiovascular disorders: an update on the principal drugs

@en

P2093

Francesco Romeo

http://www.w3.org/2001/XMLSchema#string

Irene M Predazzi

http://www.w3.org/2001/XMLSchema#string

Nicola Di Daniele

http://www.w3.org/2001/XMLSchema#string

Ruggiero Mango

http://www.w3.org/2001/XMLSchema#string

P2860

Cochrane Database of Systematic Reviews

Genome-wide association of lipid-lowering response to statins in combined study populations

Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease

CYP2C9 allelic variants: ethnic distribution and functional significance

Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

SLCO1B1 variants and statin-induced myopathy--a genomewide study

CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation.

Estimation of the warfarin dose with clinical and pharmacogenetic data.

P2888

s40256-013-0020-9

P304

79-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40256-013-0020-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Novelli

Giuseppe Danilo Norata

Domenico Sergi

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236090583

http://www.w3.org/2001/XMLSchema#string

P6179

1034263200

http://www.w3.org/2001/XMLSchema#string

P698

23539170

http://www.w3.org/2001/XMLSchema#string

Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.

about

P2860

P2860

Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698